DO
ACAD icon

denkapparat Operations’s Acadia Pharmaceuticals ACAD Stock Holding History

denkapparat Operations’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$317K Hold
12,540
– – 0.1% 327
2026
Q1 		$279K Hold
12,540
– – 0.12% 288
2025
Q4 		$335K Hold
12,540
– – 0.18% 220
2025
Q3 		$268K Hold
12,540
– – 0.17% 222
2025
Q2 		$270K Hold
12,540
– – 0.22% 194
2025
Q1 		$208K Buy
12,540
+1,914
+18% +$34.8K 0.22% 201
2024
Q4 		$195K Buy
+10,626
New +$172K 0.29% 161

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

denkapparat Operations's ACAD Position: Q2 2026 in Review

denkapparat Operations held its Acadia Pharmaceuticals (ACAD) position steady in Q2 2026 at 12,540 shares worth $317K. The position accounts for 0.1% of the portfolio, ranked #327.

denkapparat Operations first reported a position in ACAD in Q4 2024 and has held it in 7 quarters since. The position peaked at $335K in Q4 2025. 354 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

  • denkapparat Operations held 12,540 shares of Acadia Pharmaceuticals worth $317K as of Q2 2026.
  • denkapparat Operations left its Acadia Pharmaceuticals share count unchanged in Q2 2026.
  • Acadia Pharmaceuticals made up 0.1% of denkapparat Operations's portfolio in Q2 2026, its #327 holding.
  • denkapparat Operations first reported a position in Acadia Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • denkapparat Operations's Acadia Pharmaceuticals position peaked at $335K in Q4 2025.
  • 354 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on denkapparat Operations's 13F filing for Q2 2026, filed 6 Aug 2026.